In a recent study published in Nature Medicine,Witkowski and colleagues applied untargeted metabolomics studies in 1157 people at high risk for cardiovascular disease,comprising 22%with diabetes mellitus,followed by q...In a recent study published in Nature Medicine,Witkowski and colleagues applied untargeted metabolomics studies in 1157 people at high risk for cardiovascular disease,comprising 22%with diabetes mellitus,followed by quantitative targeted analyses to identify circulating metabolites associated with an increased cardiovascular risk.展开更多
基金The authors are supported in part by the German Diabetes Center(DDZ),which is funded by the Ministry of Culture and Science of the State of Northrhine Westphalia and the German Federal Ministry of Health(BMG),by grants of the Federal Ministry for Research(BMBF)to the German Center for Diabetes Research(DZD e.V.,DZD Grant 2016)M.R.is also supported by grants from the European Funds for Regional Development(EFRE-0400191)+1 种基金the German Research Foundation(DFG,SFB 1116/2,GRK 2576)the Schmutzler-Stiftung and the European Community(HORIZON-HLTH2022-STAYHLTH-02-01:Panel A)to the INTERCEPT-T2D consortium.
文摘In a recent study published in Nature Medicine,Witkowski and colleagues applied untargeted metabolomics studies in 1157 people at high risk for cardiovascular disease,comprising 22%with diabetes mellitus,followed by quantitative targeted analyses to identify circulating metabolites associated with an increased cardiovascular risk.
